| Metric | Current Period | YoY Comparison Period | YoY |
|---|---|---|---|
| Revenue | ¥108.2B | ¥144.6B | -25.2% |
| Operating Income | ¥-0.1B | ¥9.0B | -64.7% |
| Ordinary Income | ¥-1.1B | ¥7.6B | -71.9% |
| Net Income | ¥-0.8B | ¥5.0B | -89.6% |
| ROE | -0.4% | 2.3% | - |
The 2026 FY Q3 results showed a significant decline in revenue to 108.2B (YoY -36.4B -25.2%), with Operating Income turning to a loss of -0.1B (YoY -9.1B -64.7%), Ordinary Income at -1.1B (YoY -8.7B -71.9%), and Net Income at -0.8B (YoY -5.8B -89.6%), indicating losses at all levels. While the gross margin of 33.6% was maintained, SG&A of 36.5B exceeded gross profit of 36.4B, resulting in an operating loss, and interest expense of 0.8B further widened the ordinary loss. The Full Year outlook projects Revenue of 180.0B, Operating Income of 2.0B, Ordinary Income of 1.0B, and Net Income of 0.3B, expecting to finish in the black; however, given the large gap versus Q3 progress, stronger execution will be required to achieve the targets.
[Profitability] ROE -0.4% (deteriorated from the estimated +3.4% in the YoY comparison period), Net profit margin -0.7% (down 4.1pt from the estimated +3.4% in the YoY comparison period), Operating margin -0.1% (worsened by 6.3pt from the estimated +6.2% in the YoY comparison period). In the DuPont decomposition, Net profit margin -0.7%, Total asset turnover 0.297x, and Financial leverage 1.72x, with deterioration in net profit margin as the main driver. [Cash Quality] Cash and Deposits 5.7B (up +2.5B from 3.2B in the YoY comparison period), with short-term debt coverage at 0.21x, indicating limited liquidity headroom. Interest coverage -0.14x, reflecting insufficient capacity to service interest. [Investment Efficiency] Total asset turnover 0.297x (annualized). Inventories of 70.5B increased +66.0% YoY, showing signs of worsening inventory turnover. [Financial Soundness] Equity Ratio 58.1% (Total assets 363.8B, Net assets 211.4B), Current ratio 168.7%, Quick ratio 93.9%, Debt-to-equity ratio 0.72x, Debt/Capital ratio 20.3%. Short-term borrowings of 27.5B increased +66.7% YoY, with a short-term liabilities ratio of 50.9%, heightening short-term repayment burden.
Cash and Deposits increased by +2.5B YoY to 5.7B, but the absolute level remains limited, with coverage of short-term liabilities at only 0.21x. From balance sheet trends, Inventories increased by +28.0B (+66.0%) and Accounts payable increased by +17.3B (+82.4%), confirming deterioration in working capital due to inventory build-up and expansion of trade payables. Short-term borrowings rose by +11.0B (+66.7%) to 27.5B, indicating that the increase in working capital and the operating loss are being funded by short-term financing. Accounts receivable at 34.9B remained flat YoY; however, flat receivables amid declining sales suggest possible lengthening of collection cycles. With no disclosure of Operating Cash Flow, profitability cannot be directly corroborated by cash; however, the combination of operating losses and increased working capital points to cash outflows. The company is relying on short-term borrowings to secure liquidity, elevating refinancing risk and the importance of cash management.
With Operating Income at -0.1B versus Ordinary Income at -1.1B, non-operating expenses of 1.1B are pressuring earnings. The main component of non-operating expenses is interest expense of 0.8B, and higher short-term borrowings are worsening profitability through increased interest burden. Gross profit of 36.4B (gross margin 33.6%) indicates a certain underlying earning power from the product mix; however, SG&A of 36.5B exceeds gross profit, resulting in losses from the operating level and revealing a heavy fixed-cost burden. The -9.1B deterioration from Operating Income of 9.0B in the YoY comparison period is attributable to negative operating leverage, as SG&A remained flat against a -36.4B decline in sales. With OCF undisclosed, cash corroboration of earnings cannot be verified, but the combination of rising inventories and higher short-term borrowings suggests deterioration in earnings quality. The Payout Ratio is a calculated -612.5%, indicating that dividends cannot be covered in a net loss period; dividend sustainability depends on cash balances and external financing.
Demand fluctuation risk: Revenue was down -25.2% YoY, indicating continued significant demand deterioration, with a large gap versus the Full Year outlook. Without a substantial sales rebound in Q4, there is a risk of missing full-year targets. Inventory risk: Inventories have piled up to an abnormal level at 70.5B (+66.0% YoY), raising concerns over obsolescence losses and impairment risk. Liquidity risk: Cash/short-term liabilities at 0.21x and short-term borrowings of 27.5B indicate a high short-term repayment burden, with potential for refinancing and funding stress. Interest burden risk: Interest coverage at -0.14x already indicates insufficient capacity to service interest; additional borrowings or a rising interest rate environment would accelerate financial pressure. SG&A rigidity risk: SG&A is fixed at a level exceeding gross profit, making it difficult to improve Operating Income without a recovery in sales.
[Position within Industry] (Reference information; our research) Profitability: Net profit margin -0.7% (industry median 5.4%, IQR 3.5%–8.9%), significantly below the industry. Operating margin -0.1% (industry median 7.3%, IQR 4.6%–12.0%) is also at the bottom of the industry. ROE -0.4% (industry median 4.9%, IQR 2.8%–8.2%) is inferior within the industry. Growth: Revenue growth -25.2% (industry median +2.8%, IQR -0.9%–+7.9%), contrarian to industry trends. Soundness: Equity Ratio 58.1% (industry median 63.9%, IQR 51.5%–72.3%) is mid-range within the industry and relatively conservative, but the Current ratio 168.7% (industry median 267%, IQR 200%–356%) is low within the industry. Overall: Profitability and growth significantly lag industry peers, and soundness indicators are also at or below mid-range. Relative underperformance and financial stress concerns are evident within the manufacturing sector. Note: Industry: Manufacturing (N=65 companies), Comparison: 2025 Q3, Source: Our aggregation of public financial data
The most notable point is the shift to an operating loss driven by declining sales and fixed SG&A, with sales recovery in Q4 and execution of SG&A reductions being key to achieving the Full Year outlook. The abnormal build-up of inventories (+66.0% YoY) and simultaneous increase in short-term borrowings (+66.7% YoY) signal deteriorating working capital efficiency and liquidity stress; inventory normalization and working capital compression are urgent management priorities. The combination of interest coverage at -0.14x and Cash/short-term liabilities at 0.21x indicates vulnerability in both interest servicing capacity and short-term repayment headroom, making concrete refinancing plans and cash management measures critical items to confirm.
This report is an earnings analysis document automatically generated by AI based on XBRL financial statement data. It does not constitute a recommendation to invest in any specific security. The industry benchmark is reference information compiled by our company based on public financial data. Investment decisions are your own responsibility; consult a professional as needed before making any investment decisions.